Michael Hadjisavas has been a leader in the Life Sciences, Applied Markets and Diagnostics industries for over 20 years, including 10 years focusing on genomics, translational research, bioinformatics and molecular diagnostics. He currently serves as VP of Assay Technologies, Head of Life Sciences Portfolio Strategy and previously as VP Clinical Genomics and Bioinformatics at QIAGEN, Inc. His prior positions include executive and senior leadership roles at: Abcam PLC, Gen-Probe/Hologic, Life Technologies/Thermo, and Sigma-Aldrich. His commercial and operational experience includes portfolio responsibilities for systems, consumables and software for the research, pharmaceutical, and diagnostics segments. He has also held numerous strategic advisory roles for various early stage genomics, bioinformatics and diagnostic companies. He holds B.Sc., Honors and Ph.D. degrees in molecular and cellular biology from the University of Adelaide, Australia with post-doctoral training at Texas A&M University. He has an abounding passion and deep commitment for implementing advanced technologies in healthcare.